VIVITRA 440MG INJ
Prescription Required
Sale price
₹ 7,100.00
Regular price
MRP: ₹ 38,871.94
82% OFF
Inclusive of all taxes.
Couldn't load pickup availability
VIVITRA 440MG INJ
Regular price
₹ 7,100.00
Regular price
₹ 38,871.94
Sale price
₹ 7,100.00
(-82%)
Unit price
per
VIVITRA 440MG INJ
Sale price
₹ 7,100.00
Regular price
MRP: ₹ 38,871.94
82% OFF
- Introduction
- Uses
- Storage
- Safety
- Side effects
- Abouts RareMeds
- Disclaimer
Introduction
Vivitra 440mg Injection contains trastuzumab, a monoclonal antibody that targets HER2 receptors to inhibit the growth of HER2-positive cancer cells.
Uses
Vivitra 440mg Injection is used for the treatment of HER2-positive breast cancer and HER2-positive metastatic gastric cancer.
- HER2-positive breast cancer
- HER2-positive metastatic gastric cancer
Storage
- Store refrigerated at 2°C–8°C.
- Do not freeze.
- Protect from light.
Safety Information
- Monitor cardiac function before and during treatment.
- Administer only under oncology supervision.
Possible Side Effects
Possible side effects may include:
- Infusion reactions
- Fever
- Nausea
- Fatigue
- Diarrhoea
- Reduced heart function
About RareMeds
We, at RareMeds, make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed medicine-related information to our consumers. However, it should, by no means, be considered a substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact, we detest any form of self-medication without expert advice.
The sole purpose of the information on our portal is to educate our consumers, which helps improve communication between a doctor and a patient. The information is by no means complete in its entirety and should not be used to diagnose or treat any medical condition.
No amount of information can replace the experience and expertise of a doctor; therefore, his/her advice always holds priority and should be followed appropriately.
Disclaimer
Vivitra is a prescription anticancer medicine.
It should only be administered under the supervision of a qualified oncologist.